nodes	percent_of_prediction	percent_of_DWPC	metapath
Antipyrine—CYP3A4—bone cancer	0.349	0.505	CbGaD
Antipyrine—PTGS2—bone cancer	0.342	0.495	CbGaD
Antipyrine—PTGS2—Cisplatin—bone cancer	0.0585	0.309	CbGbCtD
Antipyrine—CYP2B6—Cisplatin—bone cancer	0.0377	0.199	CbGbCtD
Antipyrine—SLC22A6—Methotrexate—bone cancer	0.0281	0.149	CbGbCtD
Antipyrine—CYP2B6—Doxorubicin—bone cancer	0.0252	0.133	CbGbCtD
Antipyrine—CYP2C9—Cisplatin—bone cancer	0.0199	0.105	CbGbCtD
Antipyrine—TRPA1—trigeminal nerve—bone cancer	0.0195	0.416	CbGeAlD
Antipyrine—TRPA1—cranial nerve—bone cancer	0.0139	0.297	CbGeAlD
Antipyrine—CYP2D6—Doxorubicin—bone cancer	0.0122	0.0644	CbGbCtD
Antipyrine—CYP3A4—Doxorubicin—bone cancer	0.00775	0.0409	CbGbCtD
Antipyrine—PTGS2—periosteum—bone cancer	0.00229	0.0489	CbGeAlD
Antipyrine—TRPA1—spinal cord—bone cancer	0.0019	0.0406	CbGeAlD
Antipyrine—PTGS2—leg—bone cancer	0.00183	0.039	CbGeAlD
Antipyrine—PTGS2—hindlimb—bone cancer	0.00163	0.0348	CbGeAlD
Antipyrine—PTGS2—cartilage tissue—bone cancer	0.00161	0.0343	CbGeAlD
Antipyrine—PTGS2—appendage—bone cancer	0.0014	0.0299	CbGeAlD
Antipyrine—Aminophenazone—CYP3A4—bone cancer	0.00118	0.74	CrCbGaD
Antipyrine—CYP2D6—Xenobiotics—CYP3A4—bone cancer	0.000433	0.00606	CbGpPWpGaD
Antipyrine—CYP2C9—Xenobiotics—CYP3A4—bone cancer	0.000429	0.00601	CbGpPWpGaD
Antipyrine—CYP2B6—Constitutive Androstane Receptor Pathway—CYP3A4—bone cancer	0.000428	0.00599	CbGpPWpGaD
Antipyrine—CYP2C18—Phase 1 - Functionalization of compounds—CYP3A4—bone cancer	0.000427	0.00597	CbGpPWpGaD
Antipyrine—PTGS2—Signaling mediated by p38-alpha and p38-beta—ATF1—bone cancer	0.000425	0.00595	CbGpPWpGaD
Antipyrine—CYP2C19—Metapathway biotransformation—CYP4V2—bone cancer	0.00042	0.00588	CbGpPWpGaD
Antipyrine—PTGS1—connective tissue—bone cancer	0.000418	0.00892	CbGeAlD
Antipyrine—CYP2D6—Tamoxifen metabolism—CYP3A4—bone cancer	0.000417	0.00583	CbGpPWpGaD
Antipyrine—Clobazam—CYP3A4—bone cancer	0.000416	0.26	CrCbGaD
Antipyrine—CYP2C9—Tamoxifen metabolism—CYP3A4—bone cancer	0.000413	0.00578	CbGpPWpGaD
Antipyrine—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—NR1I2—bone cancer	0.000411	0.00575	CbGpPWpGaD
Antipyrine—CYP2A6—Quercetin and Nf-kB/ AP-1 Induced Cell Apoptosis—PTGS2—bone cancer	0.000409	0.00572	CbGpPWpGaD
Antipyrine—CYP2B6—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP3A4—bone cancer	0.000408	0.0057	CbGpPWpGaD
Antipyrine—PTGS2—connective tissue—bone cancer	0.000399	0.00853	CbGeAlD
Antipyrine—CYP2E1—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP3A4—bone cancer	0.000399	0.00559	CbGpPWpGaD
Antipyrine—CYP1A2—Estrogen metabolism—CYP3A4—bone cancer	0.000399	0.00559	CbGpPWpGaD
Antipyrine—CYP2D6—Metapathway biotransformation—CYP4V2—bone cancer	0.000386	0.0054	CbGpPWpGaD
Antipyrine—CYP2C9—Metapathway biotransformation—CYP4V2—bone cancer	0.000383	0.00536	CbGpPWpGaD
Antipyrine—CYP1A2—Aflatoxin activation and detoxification—CYP3A4—bone cancer	0.000382	0.00535	CbGpPWpGaD
Antipyrine—PTGS1—Overview of nanoparticle effects—PTGS2—bone cancer	0.000377	0.00528	CbGpPWpGaD
Antipyrine—CYP2A6—Quercetin and Nf-kB/ AP-1 Induced Cell Apoptosis—JUN—bone cancer	0.000369	0.00516	CbGpPWpGaD
Antipyrine—CYP1A2—Xenobiotics—CYP3A4—bone cancer	0.000367	0.00513	CbGpPWpGaD
Antipyrine—CYP1A2—Tamoxifen metabolism—CYP3A4—bone cancer	0.000353	0.00494	CbGpPWpGaD
Antipyrine—CYP1A2—Metapathway biotransformation—CYP4V2—bone cancer	0.000327	0.00458	CbGpPWpGaD
Antipyrine—CYP2C19—Constitutive Androstane Receptor Pathway—CYP3A4—bone cancer	0.000323	0.00452	CbGpPWpGaD
Antipyrine—CYP2A6—Cytochrome P450 - arranged by substrate type—CYP3A4—bone cancer	0.000321	0.00449	CbGpPWpGaD
Antipyrine—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—NR1I2—bone cancer	0.000317	0.00444	CbGpPWpGaD
Antipyrine—CYP2A6—Oxidation by Cytochrome P450—CYP3A4—bone cancer	0.000317	0.00443	CbGpPWpGaD
Antipyrine—CYP2E1—Tryptophan metabolism—CYP3A4—bone cancer	0.000314	0.00439	CbGpPWpGaD
Antipyrine—PTGS1—Eicosanoid Synthesis—PTGS2—bone cancer	0.000313	0.00438	CbGpPWpGaD
Antipyrine—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—IL3—bone cancer	0.000312	0.00436	CbGpPWpGaD
Antipyrine—PTGS2—Quercetin and Nf-kB/ AP-1 Induced Cell Apoptosis—JUN—bone cancer	0.00031	0.00433	CbGpPWpGaD
Antipyrine—CYP2C18—Tryptophan metabolism—MDM2—bone cancer	0.000299	0.00419	CbGpPWpGaD
Antipyrine—CYP2E1—tendon—bone cancer	0.000298	0.00637	CbGeAlD
Antipyrine—CYP2C9—Constitutive Androstane Receptor Pathway—CYP3A4—bone cancer	0.000295	0.00413	CbGpPWpGaD
Antipyrine—CYP2E1—spinal cord—bone cancer	0.000288	0.00614	CbGeAlD
Antipyrine—PTGS1—tendon—bone cancer	0.000287	0.00613	CbGeAlD
Antipyrine—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP3A4—bone cancer	0.000281	0.00393	CbGpPWpGaD
Antipyrine—PTGS1—spinal cord—bone cancer	0.000277	0.00591	CbGeAlD
Antipyrine—PTGS1—Phase 1 - Functionalization of compounds—CYP3A4—bone cancer	0.000275	0.00385	CbGpPWpGaD
Antipyrine—PTGS2—tendon—bone cancer	0.000275	0.00586	CbGeAlD
Antipyrine—CYP2C18—FOXA1 transcription factor network—JUN—bone cancer	0.00027	0.00377	CbGpPWpGaD
Antipyrine—PTGS2—bone marrow—bone cancer	0.000266	0.00568	CbGeAlD
Antipyrine—PTGS2—spinal cord—bone cancer	0.000265	0.00565	CbGeAlD
Antipyrine—PTGS1—Prostaglandin Synthesis and Regulation—PTGS2—bone cancer	0.000262	0.00366	CbGpPWpGaD
Antipyrine—CYP2A6—Phase 1 - Functionalization of compounds—CYP3A4—bone cancer	0.00026	0.00364	CbGpPWpGaD
Antipyrine—CYP2B6—Cytochrome P450 - arranged by substrate type—CYP3A4—bone cancer	0.000259	0.00362	CbGpPWpGaD
Antipyrine—CYP2B6—Oxidation by Cytochrome P450—CYP3A4—bone cancer	0.000255	0.00357	CbGpPWpGaD
Antipyrine—CYP2E1—Cytochrome P450 - arranged by substrate type—CYP3A4—bone cancer	0.000253	0.00355	CbGpPWpGaD
Antipyrine—CYP3A4—Metapathway biotransformation—CYP4V2—bone cancer	0.000253	0.00353	CbGpPWpGaD
Antipyrine—CYP2E1—Oxidation by Cytochrome P450—CYP3A4—bone cancer	0.00025	0.0035	CbGpPWpGaD
Antipyrine—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP3A4—bone cancer	0.00024	0.00336	CbGpPWpGaD
Antipyrine—PTGS2—Defective AMN causes hereditary megaloblastic anemia 1—DHFR—bone cancer	0.000236	0.0033	CbGpPWpGaD
Antipyrine—CYP2C18—Biological oxidations—CYP3A4—bone cancer	0.000227	0.00317	CbGpPWpGaD
Antipyrine—CYP2C18—Metapathway biotransformation—CYP3A4—bone cancer	0.000224	0.00313	CbGpPWpGaD
Antipyrine—CYP2C8—Cytochrome P450 - arranged by substrate type—CYP3A4—bone cancer	0.000219	0.00307	CbGpPWpGaD
Antipyrine—CYP2C8—Oxidation by Cytochrome P450—CYP3A4—bone cancer	0.000216	0.00303	CbGpPWpGaD
Antipyrine—CYP2B6—Phase 1 - Functionalization of compounds—CYP3A4—bone cancer	0.00021	0.00294	CbGpPWpGaD
Antipyrine—CYP1A2—Estrogen Receptor Pathway—JUN—bone cancer	0.000207	0.0029	CbGpPWpGaD
Antipyrine—CYP2E1—Phase 1 - Functionalization of compounds—CYP3A4—bone cancer	0.000205	0.00287	CbGpPWpGaD
Antipyrine—CYP2C19—Cytochrome P450 - arranged by substrate type—CYP3A4—bone cancer	0.000196	0.00274	CbGpPWpGaD
Antipyrine—CYP2C18—Biological oxidations—GSTP1—bone cancer	0.000194	0.00271	CbGpPWpGaD
Antipyrine—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—CDK4—bone cancer	0.000193	0.0027	CbGpPWpGaD
Antipyrine—CYP2C19—Oxidation by Cytochrome P450—CYP3A4—bone cancer	0.000193	0.0027	CbGpPWpGaD
Antipyrine—PTGS2—Calcium signaling in the CD4+ TCR pathway—JUN—bone cancer	0.000192	0.00269	CbGpPWpGaD
Antipyrine—CYP2C18—Metapathway biotransformation—GSTP1—bone cancer	0.000191	0.00268	CbGpPWpGaD
Antipyrine—CYP1A2—Tryptophan metabolism—CYP3A4—bone cancer	0.000188	0.00264	CbGpPWpGaD
Antipyrine—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP3A4—bone cancer	0.00018	0.00252	CbGpPWpGaD
Antipyrine—PTGS2—Aryl Hydrocarbon Receptor—RB1—bone cancer	0.00018	0.00251	CbGpPWpGaD
Antipyrine—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP3A4—bone cancer	0.000178	0.00249	CbGpPWpGaD
Antipyrine—CYP2C8—Phase 1 - Functionalization of compounds—CYP3A4—bone cancer	0.000178	0.00249	CbGpPWpGaD
Antipyrine—CYP2D6—Oxidation by Cytochrome P450—CYP3A4—bone cancer	0.000178	0.00248	CbGpPWpGaD
Antipyrine—CYP2C9—Oxidation by Cytochrome P450—CYP3A4—bone cancer	0.000176	0.00246	CbGpPWpGaD
Antipyrine—PTGS1—Arachidonic acid metabolism—PTGS2—bone cancer	0.000174	0.00243	CbGpPWpGaD
Antipyrine—PTGS2—Signaling mediated by p38-alpha and p38-beta—JUN—bone cancer	0.000166	0.00232	CbGpPWpGaD
Antipyrine—CYP2C19—Phase 1 - Functionalization of compounds—CYP3A4—bone cancer	0.000159	0.00222	CbGpPWpGaD
Antipyrine—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP3A4—bone cancer	0.000152	0.00213	CbGpPWpGaD
Antipyrine—PTGS2—Integrated Pancreatic Cancer Pathway—WT1—bone cancer	0.000151	0.00212	CbGpPWpGaD
Antipyrine—CYP1A2—Oxidation by Cytochrome P450—CYP3A4—bone cancer	0.00015	0.0021	CbGpPWpGaD
Antipyrine—PTGS1—Biological oxidations—CYP3A4—bone cancer	0.000146	0.00204	CbGpPWpGaD
Antipyrine—CYP2D6—Phase 1 - Functionalization of compounds—CYP3A4—bone cancer	0.000146	0.00204	CbGpPWpGaD
Antipyrine—CYP2C9—Phase 1 - Functionalization of compounds—CYP3A4—bone cancer	0.000145	0.00202	CbGpPWpGaD
Antipyrine—CYP2E1—Tryptophan metabolism—MDM2—bone cancer	0.000144	0.00202	CbGpPWpGaD
Antipyrine—SLC22A6—Transmembrane transport of small molecules—TUBB4B—bone cancer	0.000138	0.00194	CbGpPWpGaD
Antipyrine—CYP2A6—Biological oxidations—CYP3A4—bone cancer	0.000138	0.00193	CbGpPWpGaD
Antipyrine—CYP2A6—Fluoropyrimidine Activity—TP53—bone cancer	0.000136	0.00191	CbGpPWpGaD
Antipyrine—CYP2C18—Metabolism—NDUFA12—bone cancer	0.000136	0.0019	CbGpPWpGaD
Antipyrine—CYP2A6—NRF2 pathway—GSTP1—bone cancer	0.000135	0.00188	CbGpPWpGaD
Antipyrine—CYP2A6—NRF2 pathway—TGFBR2—bone cancer	0.000135	0.00188	CbGpPWpGaD
Antipyrine—PTGS2—Integrated Pancreatic Cancer Pathway—SMO—bone cancer	0.000129	0.0018	CbGpPWpGaD
Antipyrine—PTGS1—Biological oxidations—GSTP1—bone cancer	0.000125	0.00175	CbGpPWpGaD
Antipyrine—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—JUN—bone cancer	0.000124	0.00174	CbGpPWpGaD
Antipyrine—CYP1A2—Phase 1 - Functionalization of compounds—CYP3A4—bone cancer	0.000124	0.00173	CbGpPWpGaD
Antipyrine—PTGS2—C-MYB transcription factor network—KIT—bone cancer	0.00012	0.00168	CbGpPWpGaD
Antipyrine—SLC22A6—Transmembrane transport of small molecules—TUBB2A—bone cancer	0.000119	0.00167	CbGpPWpGaD
Antipyrine—CYP2A6—Biological oxidations—GSTP1—bone cancer	0.000118	0.00165	CbGpPWpGaD
Antipyrine—PTGS2—Integrated Pancreatic Cancer Pathway—EZH2—bone cancer	0.000117	0.00164	CbGpPWpGaD
Antipyrine—CYP2C18—Metabolism—NT5C3A—bone cancer	0.000113	0.00158	CbGpPWpGaD
Antipyrine—CYP2C8—Arachidonic acid metabolism—PTGS2—bone cancer	0.000112	0.00157	CbGpPWpGaD
Antipyrine—CYP2B6—Biological oxidations—CYP3A4—bone cancer	0.000111	0.00156	CbGpPWpGaD
Antipyrine—PTGS1—Selenium Micronutrient Network—PTGS2—bone cancer	0.000111	0.00155	CbGpPWpGaD
Antipyrine—CYP2B6—Metapathway biotransformation—CYP3A4—bone cancer	0.00011	0.00154	CbGpPWpGaD
Antipyrine—PTGS2—Signaling mediated by p38-alpha and p38-beta—TP53—bone cancer	0.000109	0.00153	CbGpPWpGaD
Antipyrine—CYP2E1—Biological oxidations—CYP3A4—bone cancer	0.000109	0.00153	CbGpPWpGaD
Antipyrine—CYP2E1—Metapathway biotransformation—CYP3A4—bone cancer	0.000108	0.00151	CbGpPWpGaD
Antipyrine—PTGS2—Integrated Pancreatic Cancer Pathway—IL3—bone cancer	0.000107	0.00149	CbGpPWpGaD
Antipyrine—PTGS2—Integrated Pancreatic Cancer Pathway—CHEK2—bone cancer	0.000105	0.00147	CbGpPWpGaD
Antipyrine—PTGS2—Aryl Hydrocarbon Receptor—EGFR—bone cancer	0.000105	0.00146	CbGpPWpGaD
Antipyrine—CYP1A2—Aryl Hydrocarbon Receptor—RB1—bone cancer	0.000102	0.00142	CbGpPWpGaD
Antipyrine—CYP2C19—Arachidonic acid metabolism—PTGS2—bone cancer	0.0001	0.0014	CbGpPWpGaD
Antipyrine—PTGS2—Spinal Cord Injury—CDK4—bone cancer	9.72e-05	0.00136	CbGpPWpGaD
Antipyrine—CYP1A2—Phase II conjugation—GSTP1—bone cancer	9.59e-05	0.00134	CbGpPWpGaD
Antipyrine—CYP2B6—Biological oxidations—GSTP1—bone cancer	9.53e-05	0.00133	CbGpPWpGaD
Antipyrine—CYP2C8—Biological oxidations—CYP3A4—bone cancer	9.44e-05	0.00132	CbGpPWpGaD
Antipyrine—CYP2B6—Metapathway biotransformation—GSTP1—bone cancer	9.4e-05	0.00132	CbGpPWpGaD
Antipyrine—CYP2E1—Biological oxidations—GSTP1—bone cancer	9.34e-05	0.00131	CbGpPWpGaD
Antipyrine—CYP2C8—Metapathway biotransformation—CYP3A4—bone cancer	9.31e-05	0.0013	CbGpPWpGaD
Antipyrine—CYP2E1—Metapathway biotransformation—GSTP1—bone cancer	9.21e-05	0.00129	CbGpPWpGaD
Antipyrine—CYP2C9—Arachidonic acid metabolism—PTGS2—bone cancer	9.14e-05	0.00128	CbGpPWpGaD
Antipyrine—PTGS2—Integrated Pancreatic Cancer Pathway—BRCA2—bone cancer	8.91e-05	0.00125	CbGpPWpGaD
Antipyrine—PTGS1—Metabolism—NDUFA12—bone cancer	8.76e-05	0.00122	CbGpPWpGaD
Antipyrine—CYP1A2—Tryptophan metabolism—MDM2—bone cancer	8.66e-05	0.00121	CbGpPWpGaD
Antipyrine—PTGS2—Spinal Cord Injury—RB1—bone cancer	8.45e-05	0.00118	CbGpPWpGaD
Antipyrine—CYP2C19—Biological oxidations—CYP3A4—bone cancer	8.42e-05	0.00118	CbGpPWpGaD
Antipyrine—CYP1A2—Aryl Hydrocarbon Receptor—PTGS2—bone cancer	8.35e-05	0.00117	CbGpPWpGaD
Antipyrine—CYP2C19—Metapathway biotransformation—CYP3A4—bone cancer	8.31e-05	0.00116	CbGpPWpGaD
Antipyrine—CYP2A6—Metabolism—NDUFA12—bone cancer	8.28e-05	0.00116	CbGpPWpGaD
Antipyrine—CYP2C8—Biological oxidations—GSTP1—bone cancer	8.07e-05	0.00113	CbGpPWpGaD
Antipyrine—CYP2C8—Metapathway biotransformation—GSTP1—bone cancer	7.96e-05	0.00111	CbGpPWpGaD
Antipyrine—CYP1A2—Arachidonic acid metabolism—PTGS2—bone cancer	7.81e-05	0.00109	CbGpPWpGaD
Antipyrine—CYP2D6—Biological oxidations—CYP3A4—bone cancer	7.75e-05	0.00108	CbGpPWpGaD
Antipyrine—CYP2C9—Biological oxidations—CYP3A4—bone cancer	7.68e-05	0.00107	CbGpPWpGaD
Antipyrine—CYP2D6—Metapathway biotransformation—CYP3A4—bone cancer	7.64e-05	0.00107	CbGpPWpGaD
Antipyrine—CYP2C9—Metapathway biotransformation—CYP3A4—bone cancer	7.57e-05	0.00106	CbGpPWpGaD
Antipyrine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—JUN—bone cancer	7.53e-05	0.00105	CbGpPWpGaD
Antipyrine—PTGS1—Metabolism—NT5C3A—bone cancer	7.25e-05	0.00102	CbGpPWpGaD
Antipyrine—CYP2C19—Biological oxidations—GSTP1—bone cancer	7.2e-05	0.00101	CbGpPWpGaD
Antipyrine—CYP2C19—Metapathway biotransformation—GSTP1—bone cancer	7.1e-05	0.000994	CbGpPWpGaD
Antipyrine—PTGS2—Metabolism—NDUFA12—bone cancer	6.95e-05	0.000972	CbGpPWpGaD
Antipyrine—CYP2A6—Metabolism—NT5C3A—bone cancer	6.86e-05	0.00096	CbGpPWpGaD
Antipyrine—CYP3A4—Tryptophan metabolism—MDM2—bone cancer	6.69e-05	0.000935	CbGpPWpGaD
Antipyrine—CYP2B6—Metabolism—NDUFA12—bone cancer	6.68e-05	0.000935	CbGpPWpGaD
Antipyrine—CYP2D6—Biological oxidations—GSTP1—bone cancer	6.62e-05	0.000927	CbGpPWpGaD
Antipyrine—PTGS2—Integrated Pancreatic Cancer Pathway—CDK4—bone cancer	6.61e-05	0.000925	CbGpPWpGaD
Antipyrine—CYP2C9—Biological oxidations—GSTP1—bone cancer	6.57e-05	0.000919	CbGpPWpGaD
Antipyrine—CYP1A2—Biological oxidations—CYP3A4—bone cancer	6.56e-05	0.000918	CbGpPWpGaD
Antipyrine—CYP2E1—Metabolism—NDUFA12—bone cancer	6.54e-05	0.000915	CbGpPWpGaD
Antipyrine—CYP2D6—Metapathway biotransformation—GSTP1—bone cancer	6.53e-05	0.000914	CbGpPWpGaD
Antipyrine—CYP2C9—Metapathway biotransformation—GSTP1—bone cancer	6.48e-05	0.000906	CbGpPWpGaD
Antipyrine—CYP1A2—Metapathway biotransformation—CYP3A4—bone cancer	6.47e-05	0.000905	CbGpPWpGaD
Antipyrine—PTGS2—Spinal Cord Injury—MMP9—bone cancer	6.09e-05	0.000852	CbGpPWpGaD
Antipyrine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EGFR—bone cancer	5.92e-05	0.000828	CbGpPWpGaD
Antipyrine—CYP1A2—Aryl Hydrocarbon Receptor—EGFR—bone cancer	5.92e-05	0.000828	CbGpPWpGaD
Antipyrine—PTGS2—Metabolism—NT5C3A—bone cancer	5.76e-05	0.000806	CbGpPWpGaD
Antipyrine—CYP2C8—Metabolism—NDUFA12—bone cancer	5.66e-05	0.000791	CbGpPWpGaD
Antipyrine—CYP1A2—Biological oxidations—GSTP1—bone cancer	5.61e-05	0.000785	CbGpPWpGaD
Antipyrine—CYP2B6—Metabolism—NT5C3A—bone cancer	5.54e-05	0.000774	CbGpPWpGaD
Antipyrine—CYP1A2—Metapathway biotransformation—GSTP1—bone cancer	5.54e-05	0.000774	CbGpPWpGaD
Antipyrine—CYP2E1—Metabolism—NT5C3A—bone cancer	5.42e-05	0.000759	CbGpPWpGaD
Antipyrine—CYP2C19—Metabolism—NDUFA12—bone cancer	5.05e-05	0.000706	CbGpPWpGaD
Antipyrine—CYP2C18—Metabolism—ENO2—bone cancer	4.93e-05	0.00069	CbGpPWpGaD
Antipyrine—PTGS2—Spinal Cord Injury—EGFR—bone cancer	4.92e-05	0.000689	CbGpPWpGaD
Antipyrine—PTGS2—Integrated Pancreatic Cancer Pathway—MDM2—bone cancer	4.9e-05	0.000686	CbGpPWpGaD
Antipyrine—CYP2C8—Metabolism—NT5C3A—bone cancer	4.69e-05	0.000656	CbGpPWpGaD
Antipyrine—CYP2D6—Metabolism—NDUFA12—bone cancer	4.64e-05	0.00065	CbGpPWpGaD
Antipyrine—CYP2C9—Metabolism—NDUFA12—bone cancer	4.6e-05	0.000644	CbGpPWpGaD
Antipyrine—CYP2C18—Metabolism—DHFR—bone cancer	4.58e-05	0.00064	CbGpPWpGaD
Antipyrine—CYP3A4—Biological oxidations—GSTP1—bone cancer	4.33e-05	0.000606	CbGpPWpGaD
Antipyrine—CYP2C18—Metabolism—GNA11—bone cancer	4.28e-05	0.000598	CbGpPWpGaD
Antipyrine—CYP3A4—Metapathway biotransformation—GSTP1—bone cancer	4.27e-05	0.000598	CbGpPWpGaD
Antipyrine—PTGS2—Integrated Pancreatic Cancer Pathway—JUN—bone cancer	4.26e-05	0.000596	CbGpPWpGaD
Antipyrine—CYP2C19—Metabolism—NT5C3A—bone cancer	4.18e-05	0.000585	CbGpPWpGaD
Antipyrine—PTGS2—Spinal Cord Injury—TP53—bone cancer	4.13e-05	0.000578	CbGpPWpGaD
Antipyrine—CYP1A2—Metabolism—NDUFA12—bone cancer	3.93e-05	0.00055	CbGpPWpGaD
Antipyrine—CYP2C18—Metabolism—CYP3A4—bone cancer	3.88e-05	0.000542	CbGpPWpGaD
Antipyrine—CYP2D6—Metabolism—NT5C3A—bone cancer	3.85e-05	0.000538	CbGpPWpGaD
Antipyrine—CYP2C9—Metabolism—NT5C3A—bone cancer	3.81e-05	0.000534	CbGpPWpGaD
Antipyrine—PTGS2—Integrated Pancreatic Cancer Pathway—EGFR—bone cancer	3.35e-05	0.000469	CbGpPWpGaD
Antipyrine—CYP2C18—Metabolism—GSTP1—bone cancer	3.32e-05	0.000464	CbGpPWpGaD
Antipyrine—CYP1A2—Metabolism—NT5C3A—bone cancer	3.26e-05	0.000456	CbGpPWpGaD
Antipyrine—PTGS1—Metabolism—ENO2—bone cancer	3.18e-05	0.000445	CbGpPWpGaD
Antipyrine—CYP3A4—Metabolism—NDUFA12—bone cancer	3.04e-05	0.000425	CbGpPWpGaD
Antipyrine—PTGS2—Disease—ENO2—bone cancer	3.01e-05	0.000421	CbGpPWpGaD
Antipyrine—CYP2A6—Metabolism—ENO2—bone cancer	3.01e-05	0.00042	CbGpPWpGaD
Antipyrine—PTGS1—Metabolism—DHFR—bone cancer	2.95e-05	0.000412	CbGpPWpGaD
Antipyrine—PTGS2—Integrated Pancreatic Cancer Pathway—TP53—bone cancer	2.81e-05	0.000393	CbGpPWpGaD
Antipyrine—PTGS2—Disease—DHFR—bone cancer	2.79e-05	0.000391	CbGpPWpGaD
Antipyrine—CYP2A6—Metabolism—DHFR—bone cancer	2.79e-05	0.00039	CbGpPWpGaD
Antipyrine—PTGS1—Metabolism—GNA11—bone cancer	2.76e-05	0.000385	CbGpPWpGaD
Antipyrine—CYP2A6—Metabolism—GNA11—bone cancer	2.61e-05	0.000365	CbGpPWpGaD
Antipyrine—PTGS2—Metabolism—ENO2—bone cancer	2.52e-05	0.000353	CbGpPWpGaD
Antipyrine—CYP3A4—Metabolism—NT5C3A—bone cancer	2.52e-05	0.000352	CbGpPWpGaD
Antipyrine—PTGS1—Metabolism—CYP3A4—bone cancer	2.5e-05	0.000349	CbGpPWpGaD
Antipyrine—PTGS1—Metabolism of lipids and lipoproteins—PTGS2—bone cancer	2.49e-05	0.000348	CbGpPWpGaD
Antipyrine—CYP2B6—Metabolism—ENO2—bone cancer	2.42e-05	0.000339	CbGpPWpGaD
Antipyrine—CYP2E1—Metabolism—ENO2—bone cancer	2.37e-05	0.000332	CbGpPWpGaD
Antipyrine—CYP2A6—Metabolism—CYP3A4—bone cancer	2.36e-05	0.00033	CbGpPWpGaD
Antipyrine—PTGS2—Metabolism—DHFR—bone cancer	2.34e-05	0.000327	CbGpPWpGaD
Antipyrine—CYP2B6—Metabolism—DHFR—bone cancer	2.25e-05	0.000315	CbGpPWpGaD
Antipyrine—CYP2E1—Metabolism—DHFR—bone cancer	2.2e-05	0.000308	CbGpPWpGaD
Antipyrine—PTGS2—Metabolism—GNA11—bone cancer	2.19e-05	0.000306	CbGpPWpGaD
Antipyrine—PTGS1—Metabolism—GSTP1—bone cancer	2.14e-05	0.000299	CbGpPWpGaD
Antipyrine—CYP2B6—Metabolism—GNA11—bone cancer	2.1e-05	0.000294	CbGpPWpGaD
Antipyrine—CYP2E1—Metabolism—GNA11—bone cancer	2.06e-05	0.000288	CbGpPWpGaD
Antipyrine—CYP2C8—Metabolism—ENO2—bone cancer	2.05e-05	0.000287	CbGpPWpGaD
Antipyrine—PTGS2—Disease—TGFBR2—bone cancer	2.03e-05	0.000283	CbGpPWpGaD
Antipyrine—CYP2A6—Metabolism—GSTP1—bone cancer	2.02e-05	0.000283	CbGpPWpGaD
Antipyrine—PTGS2—Metabolism—CYP3A4—bone cancer	1.98e-05	0.000277	CbGpPWpGaD
Antipyrine—CYP2B6—Metabolism—CYP3A4—bone cancer	1.91e-05	0.000267	CbGpPWpGaD
Antipyrine—CYP2C8—Metabolism—DHFR—bone cancer	1.9e-05	0.000266	CbGpPWpGaD
Antipyrine—CYP2E1—Metabolism—CYP3A4—bone cancer	1.87e-05	0.000261	CbGpPWpGaD
Antipyrine—CYP2C19—Metabolism—ENO2—bone cancer	1.83e-05	0.000256	CbGpPWpGaD
Antipyrine—CYP2C8—Metabolism—GNA11—bone cancer	1.78e-05	0.000249	CbGpPWpGaD
Antipyrine—CYP2C18—Metabolism—PTGS2—bone cancer	1.72e-05	0.00024	CbGpPWpGaD
Antipyrine—CYP2C19—Metabolism—DHFR—bone cancer	1.7e-05	0.000238	CbGpPWpGaD
Antipyrine—PTGS2—Metabolism—GSTP1—bone cancer	1.7e-05	0.000237	CbGpPWpGaD
Antipyrine—CYP2D6—Metabolism—ENO2—bone cancer	1.69e-05	0.000236	CbGpPWpGaD
Antipyrine—CYP2C9—Metabolism—ENO2—bone cancer	1.67e-05	0.000234	CbGpPWpGaD
Antipyrine—CYP2B6—Metabolism—GSTP1—bone cancer	1.63e-05	0.000228	CbGpPWpGaD
Antipyrine—CYP2C8—Metabolism—CYP3A4—bone cancer	1.61e-05	0.000226	CbGpPWpGaD
Antipyrine—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—bone cancer	1.61e-05	0.000225	CbGpPWpGaD
Antipyrine—CYP2E1—Metabolism—GSTP1—bone cancer	1.6e-05	0.000223	CbGpPWpGaD
Antipyrine—CYP2C19—Metabolism—GNA11—bone cancer	1.59e-05	0.000222	CbGpPWpGaD
Antipyrine—CYP2D6—Metabolism—DHFR—bone cancer	1.56e-05	0.000219	CbGpPWpGaD
Antipyrine—CYP2C9—Metabolism—DHFR—bone cancer	1.55e-05	0.000217	CbGpPWpGaD
Antipyrine—CYP2D6—Metabolism—GNA11—bone cancer	1.46e-05	0.000204	CbGpPWpGaD
Antipyrine—CYP2C9—Metabolism—GNA11—bone cancer	1.45e-05	0.000203	CbGpPWpGaD
Antipyrine—CYP2C19—Metabolism—CYP3A4—bone cancer	1.44e-05	0.000201	CbGpPWpGaD
Antipyrine—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—bone cancer	1.43e-05	0.0002	CbGpPWpGaD
Antipyrine—CYP1A2—Metabolism—ENO2—bone cancer	1.43e-05	0.0002	CbGpPWpGaD
Antipyrine—PTGS2—Disease—KIT—bone cancer	1.38e-05	0.000193	CbGpPWpGaD
Antipyrine—CYP2C8—Metabolism—GSTP1—bone cancer	1.38e-05	0.000193	CbGpPWpGaD
Antipyrine—CYP2D6—Metabolism—CYP3A4—bone cancer	1.32e-05	0.000185	CbGpPWpGaD
Antipyrine—CYP1A2—Metabolism—DHFR—bone cancer	1.32e-05	0.000185	CbGpPWpGaD
Antipyrine—CYP2C9—Metabolism—CYP3A4—bone cancer	1.31e-05	0.000184	CbGpPWpGaD
Antipyrine—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—bone cancer	1.31e-05	0.000183	CbGpPWpGaD
Antipyrine—PTGS2—Disease—BRAF—bone cancer	1.3e-05	0.000182	CbGpPWpGaD
Antipyrine—CYP1A2—Metabolism—GNA11—bone cancer	1.24e-05	0.000173	CbGpPWpGaD
Antipyrine—CYP2C19—Metabolism—GSTP1—bone cancer	1.23e-05	0.000172	CbGpPWpGaD
Antipyrine—CYP2D6—Metabolism—GSTP1—bone cancer	1.13e-05	0.000159	CbGpPWpGaD
Antipyrine—CYP2C9—Metabolism—GSTP1—bone cancer	1.12e-05	0.000157	CbGpPWpGaD
Antipyrine—CYP1A2—Metabolism—CYP3A4—bone cancer	1.12e-05	0.000157	CbGpPWpGaD
Antipyrine—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—bone cancer	1.12e-05	0.000156	CbGpPWpGaD
Antipyrine—PTGS1—Metabolism—PTGS2—bone cancer	1.11e-05	0.000155	CbGpPWpGaD
Antipyrine—CYP3A4—Metabolism—ENO2—bone cancer	1.1e-05	0.000154	CbGpPWpGaD
Antipyrine—PTGS2—Disease—MDM2—bone cancer	1.09e-05	0.000152	CbGpPWpGaD
Antipyrine—CYP2A6—Metabolism—PTGS2—bone cancer	1.05e-05	0.000146	CbGpPWpGaD
Antipyrine—CYP3A4—Metabolism—DHFR—bone cancer	1.02e-05	0.000143	CbGpPWpGaD
Antipyrine—CYP1A2—Metabolism—GSTP1—bone cancer	9.6e-06	0.000134	CbGpPWpGaD
Antipyrine—CYP3A4—Metabolism—GNA11—bone cancer	9.55e-06	0.000134	CbGpPWpGaD
Antipyrine—CYP2B6—Metabolism—PTGS2—bone cancer	8.44e-06	0.000118	CbGpPWpGaD
Antipyrine—CYP2E1—Metabolism—PTGS2—bone cancer	8.27e-06	0.000116	CbGpPWpGaD
Antipyrine—PTGS2—Disease—EGFR—bone cancer	7.44e-06	0.000104	CbGpPWpGaD
Antipyrine—CYP3A4—Metabolism—GSTP1—bone cancer	7.41e-06	0.000104	CbGpPWpGaD
Antipyrine—CYP2C8—Metabolism—PTGS2—bone cancer	7.15e-06	0.0001	CbGpPWpGaD
Antipyrine—CYP2C19—Metabolism—PTGS2—bone cancer	6.38e-06	8.93e-05	CbGpPWpGaD
Antipyrine—CYP2D6—Metabolism—PTGS2—bone cancer	5.87e-06	8.21e-05	CbGpPWpGaD
Antipyrine—CYP2C9—Metabolism—PTGS2—bone cancer	5.82e-06	8.14e-05	CbGpPWpGaD
Antipyrine—CYP1A2—Metabolism—PTGS2—bone cancer	4.97e-06	6.96e-05	CbGpPWpGaD
Antipyrine—CYP3A4—Metabolism—PTGS2—bone cancer	3.84e-06	5.37e-05	CbGpPWpGaD
